Omni Partners’s Colgate-Palmolive CL Stock Holding History

Omni Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,000,000	Closed	-$74.1M	–	25
2017 Q2	$74.1M	Buy	+1,000,000	New	+$74.2M	9.49%	2

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Omni Partners's CL Position: Q4 2017 in Review

Omni Partners sold out of Colgate-Palmolive (CL) in Q4 2017, closing a stake of 44,454 shares — an estimated $3.24M sold.

Omni Partners first reported a position in CL in Q1 2017 and held it in 3 quarters. The position peaked at $3.66M in Q1 2017. 1,474 funds tracked by Wall St. Rank hold CL as of Q4 2017.

Omni Partners reported no remaining Colgate-Palmolive position as of Q4 2017 after selling out during the quarter.
Omni Partners sold 44,454 Colgate-Palmolive shares in Q4 2017, an estimated $3.24M.
Omni Partners first reported a position in Colgate-Palmolive in Q1 2017 and held it in 3 quarters.
Omni Partners's Colgate-Palmolive position peaked at $3.66M in Q1 2017.
1,474 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2017.

Based on Omni Partners's 13F filing for Q4 2017, filed 22 Jan 2018.